Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_assertion type Assertion NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_head.
- NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_assertion description "[Treatment with the efflux pump inhibitor phenyl-arginine-?-naphthylamide (PA?N) of resistant isolates with no mutations in rpoB and different RIF MICs reduced the MIC by >10-fold and restored the synergism between RIF and COL in time-kill studies, whilst it had no effect on strains carrying rpoB mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_provenance.
- NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_assertion evidence source_evidence_literature NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_provenance.
- NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_assertion SIO_000772 22055530 NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_provenance.
- NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_assertion wasDerivedFrom befree-20140225 NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_provenance.
- NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_assertion wasGeneratedBy ECO_0000203 NP404904.RALkzOSwsqJ9R2w04OvlKtiWTNyigf1gWm2frGKg-9fKo130_provenance.